BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Thursday reported a loss of $48.9 million in its fourth quarter.
On a per-share basis, the Bothell, Washington-based company said it had a loss of 97 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.
For the year, the company reported a loss of $156.3 million, or $3.23 per share, swinging to a loss in the period.
Alder BioPharmaceuticals shares have climbed slightly more than 5 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $21.90, a rise of 14 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR
Keywords: Alder BioPharmaceuticals, Earnings Report